Board members highlight IFFIm’s value at high-profile events in spring 2025
Board members highlight IFFIm’s value at high-profile events in spring 2025
8 May 2025
This spring, IFFIm Board members Rachel Turner and Ingrid van Wees took center stage at major global events, emphasising the power of innovative finance in a pivotal moment for global immunisation. Their discussions underscored how IFFIm’s model transforms long-term donor commitments into immediate funding, allowing donors to achieve rapid impact, maximise the value of their contributions and accelerate vaccine access worldwide.
Unlocking humanitarian finance: Rachel Turner at the Humanitarian Finance Summit
On 14 February, IFFIm Board member and former FCDO senior officer Rachel Turner engaged in a compelling fireside chat with IFR’s Tessa Walsh at the Humanitarian Finance Summit in London. During their discussion, Rachel reinforced the UK’s leadership role in IFFIm, and how these types of financial instruments not only enhance market stability but also strengthen health security by facilitating rapid responses to emerging and emergency health threats. She also reflected on how IFFIm’s unique features and successes in immunisation can be a model to consider for the humanitarian sector, particularly in responding to both current crises and future emergencies. The event, convened by the Humanitarian Finance Forum and AidEx, brought together senior leaders from the public and private sectors to explore the Humanitarian Innovative Finance (HIF) initiative and its role in addressing urgent global challenges.
Sustainable impact in global health: Ingrid van Wees at the KIT Conference
On 10 March in Amsterdam, IFFIm Board member Ingrid van Wees took the stage at a conference hosted by KIT Royal Tropical Institute, discussing “Driving Impact Through Sustainable, Innovative Finance in Global Health.”
During her plenary, Ingrid highlighted three key aspects of IFFIm’s approach: IFFIm’s pioneering use of vaccine bonds to accelerate funding to immunisation efforts worldwide; how high credit ratings from donor governments, like the Netherlands, enable broader financial engagement and investor confidence; and how through financial efficiency, IFFIm ensures that donor resources have the greatest possible impact on global health.
The Netherlands, one of IFFIm’s valued donors and a leader in innovative finance for development, provided a fitting venue for this discussion.
A critical moment for global health finance
With Gavi’s next replenishment on the horizon, innovative finance is essential in sustaining and scaling immunisation programs worldwide. Events like the Humanitarian Finance Summit and the KIT Conference serve as critical platforms to explore solutions such as impact investments, social bonds, insurance and blended finance that can mobilise resources and help close funding gaps to achieve global health outcomes, especially in emergency response and fragile and conflict-affected settings.
IFFIm remains a cornerstone of Gavi’s funding strategy, providing an efficient and sustainable model that transforms donor pledges into life-saving action. Long-term, predictable resources from IFFIm are necessary for countries to plan effectively and sustain their immunisation programs into the future. By shaping markets and securing vaccine supply, IFFIm ensures that immunisation efforts remain resilient and impactful in the years ahead. Additionally, by improving the health of population in Gavi countries, donors help boost productivity and stimulate economic growth.
As discussions continue, one thing is clear: The collaboration between donor governments, global health organisations and a variety of financial institutions, both public and private, is more important than ever. With continued support, the United Kingdom, the Netherlands, and other new and existing IFFIm donors can continue demonstrating how innovative finance can drive humanitarian impact, paving the way for a healthier, safer world.
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.